William E. Bondinell

Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models

Robert S. Ames, Dennis Lee, James J. Foley et al. · The Journal of Immunology · 2001 · 200 citations · Full text

Immunology, Competitive Antagonist, Immunologic Mechanism +18

Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake

Fadia E. Ali, William E. Bondinell, Penelope A. Dandridge et al. · Journal of Medicinal Chemistry · 1985 · 130 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Molecular Pharmacology +16

Chrysene and Methylchrysenes: Presence in Tobacco Smoke and Carcinogenicity23

Stephen S. Hecht, William E. Bondinell, Dietrich Hoffmann · JNCI Journal of the National Cancer Institute · 1974 · 124 citations

Tobacco Control, Tobacco Sterols, Solvent Partitioning +14

Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic

William H. Miller, Doreen Alberts, Pradip K. Bhatnagar et al. · Journal of Medicinal Chemistry · 1999 · 116 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Pharmacodynamic Modeling +16

Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide

Thomas W. Ku, Fadia E. Ali, Linda S. Barton et al. · Journal of the American Chemical Society · 1993 · 90 citations

Peptide Engineering, Altmetric Attention Score, Peptide Science +22